- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-obesity drug discovery: advances and challenges
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-24
DOI
10.1038/s41573-021-00337-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
- (2021) Qian Zhang et al. Cell Metabolism
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
- (2021) Thomas A. Wadden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
- (2021) Lone B Enebo et al. LANCET
- A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing
- (2021) Georgina K.C. Dowsett et al. Molecular Metabolism
- 679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes
- (2021) TAMER COSKUN et al. DIABETES
- The Role of GIP in the Regulation of GLP-1 Satiety and Nausea
- (2021) Matthew R. Hayes et al. DIABETES
- Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
- (2021) Rajaa Nahra et al. DIABETES CARE
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational Development of Stable PYY3–36 Peptide Y2 Receptor Agonists
- (2021) Christian Poulsen et al. PHARMACEUTICAL RESEARCH
- European Commission classifies obesity as a chronic disease
- (2021) Talha Burki Lancet Diabetes & Endocrinology
- GDF15 Induces Anorexia through Nausea and Emesis
- (2020) Tito Borner et al. Cell Metabolism
- Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens
- (2020) Juan Pablo Frias et al. DIABETES OBESITY & METABOLISM
- Metabolically Healthy Obesity
- (2020) Matthias Blüher ENDOCRINE REVIEWS
- Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
- (2020) Steven P. Marso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
- (2020) Robert F. Kushner et al. Obesity
- Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice
- (2020) Stephanie J. Alexopoulos et al. Nature Communications
- GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
- (2020) Tito Borner et al. Cell Reports
- SELECT (Semaglutide effects on cardiovascular outcomes in people with overweight or obesity) rationale and design
- (2020) Donna H. Ryan et al. AMERICAN HEART JOURNAL
- BAM15‐mediated mitochondrial uncoupling protects against obesity and improves glycemic control
- (2020) Christopher L Axelrod et al. EMBO Molecular Medicine
- Covid-19 and Disparities in Nutrition and Obesity
- (2020) Matthew J. Belanger et al. NEW ENGLAND JOURNAL OF MEDICINE
- How May GIP Enhance the Therapeutic Efficacy of GLP-1?
- (2020) Ricardo J. Samms et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis
- (2020) Jessica A. Huthmacher et al. DIABETES CARE
- Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study
- (2020) Lena M.S. Carlsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- GDF15, an update of the physiological and pathological roles it plays: a review
- (2020) Artin Assadi et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes
- (2020) Olof Eriksson et al. Scientific Reports
- Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects
- (2020) Gabriella Milos et al. Translational Psychiatry
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
- (2020) Karine Clément et al. Lancet Diabetes & Endocrinology
- The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
- (2020) Thinzar Min et al. Diabetes Therapy
- Growth differentiation factor 15 as a potential therapeutic for treating obesity
- (2020) Clarence Hale et al. Molecular Metabolism
- 2,4 Dinitrophenol as Medicine
- (2019) John Geisler Cells
- Obesity: global epidemiology and pathogenesis
- (2019) Matthias Blüher Nature Reviews Endocrinology
- Determining the Effects of Combined Liraglutide and Phentermine on Metabolic Parameters, Blood Pressure, and Heart Rate in Lean and Obese Male Mice
- (2019) Stephanie E. Simonds et al. DIABETES
- Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation
- (2019) Sharma et al. MOLECULES
- Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases
- (2019) Demine et al. Cells
- Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake
- (2019) Alice E. Adriaenssens et al. Cell Metabolism
- Human Amylin: From Pathology to Physiology and Pharmacology
- (2019) Wei Ling et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- LEAP2 changes with body mass and food intake in humans and mice
- (2019) Bharath K. Mani et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Glucagon Regulation of Energy Expenditure
- (2019) Maximilian Kleinert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system
- (2019) A.E. Adriaenssens et al. PEPTIDES
- Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes
- (2019) Roberto Visentin et al. DIABETES OBESITY & METABOLISM
- Fasting induces remodeling of the orexigenic projections from the arcuate nucleus to the hypothalamic paraventricular nucleus, in a growth hormone secretagogue receptor–dependent manner
- (2019) Agustina Cabral et al. Molecular Metabolism
- Genetic syndromes of severe insulin resistance
- (2018) A Melvin et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis
- (2018) Rohan Khera et al. GASTROENTEROLOGY
- Comprehensive review of cardiovascular toxicity of drugs and related agents
- (2018) Přemysl Mladěnka et al. MEDICINAL RESEARCH REVIEWS
- MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
- (2018) Karine Clément et al. NATURE MEDICINE
- Accurate diagnosis of diabetes mellitus and new paradigms of classification
- (2018) Sudesna Chatterjee et al. Nature Reviews Endocrinology
- Animal models of obesity and diabetes mellitus
- (2018) Maximilian Kleinert et al. Nature Reviews Endocrinology
- Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes
- (2018) Lise G. Bjerregaard et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial
- (2018) Soraya Allas et al. PLoS One
- Metabolically healthy obesity: the low-hanging fruit in obesity treatment?
- (2018) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
- (2018) Christina Neuner Boyle et al. Molecular Metabolism
- The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases
- (2018) Vicky W.W. Tsai et al. Cell Metabolism
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
- (2018) T. D. Müller et al. PHARMACOLOGICAL REVIEWS
- Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis
- (2018) Miriam S. Udler et al. PLOS MEDICINE
- Cold exposure induces nuclear translocation of CRTC3 in brown adipose tissue
- (2018) Ziye Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial
- (2018) Juan Pablo Frias et al. LANCET
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
- (2018) Stephen T. Buckley et al. Science Translational Medicine
- “Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
- (2018) Richard D. DiMarchi Molecular Metabolism
- Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
- (2018) Piotr A. Mroz et al. Molecular Metabolism
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Relation between weight loss and causes of death in patients with cardiovascular disease
- (2017) Aldo P. Maggioni et al. Journal of Cardiovascular Medicine
- GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates
- (2017) Shannon E Mullican et al. NATURE MEDICINE
- Current pharmacotherapy for obesity
- (2017) Gitanjali Srivastava et al. Nature Reviews Endocrinology
- Toward a Wiring Diagram Understanding of Appetite Control
- (2017) Mark L. Andermann et al. NEURON
- Mechanisms, Pathophysiology, and Management of Obesity
- (2017) Steven B. Heymsfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight and Metabolic Outcomes 12 Years after Gastric Bypass
- (2017) Ted D. Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Emerging Poly-Agonists for Obesity and Type 2 Diabetes
- (2017) Maximilian Kleinert et al. Obesity
- Efficacy and Safety of Cathine (Nor-Pseudoephedrine) in the Treatment of Obesity: A Randomized Dose-Finding Study
- (2017) Hans Hauner et al. Obesity Facts
- Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation
- (2017) G.A. Bray et al. Obesity Reviews
- The New Biology and Pharmacology of Glucagon
- (2017) T. D. Müller et al. PHYSIOLOGICAL REVIEWS
- Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
- (2017) Tinh-Hai Collet et al. Molecular Metabolism
- Meta-Analysis of Short Sleep Duration and Obesity in Children and Adults
- (2017) Francesco P. Cappuccio et al. SLEEP
- KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight
- (2016) Sofie Gydesen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Role of lateral septum glucagon-like peptide 1 receptors in food intake
- (2016) Sarah J. Terrill et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development
- (2016) Rebekah L Bower et al. BRITISH JOURNAL OF PHARMACOLOGY
- Obesity and cancer: An update of the global impact
- (2016) Melina Arnold et al. Cancer Epidemiology
- Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
- (2016) Faidon Magkos et al. Cell Metabolism
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
- (2016) Matthias H. Tschöp et al. Cell Metabolism
- Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
- (2016) Jean L. Chan et al. CLINICAL ENDOCRINOLOGY
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of obesity
- (2016) George A Bray et al. LANCET
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
- (2016) Emanuele Di Angelantonio et al. LANCET
- Epigenetic germline inheritance of diet-induced obesity and insulin resistance
- (2016) Peter Huypens et al. NATURE GENETICS
- Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
- (2016) Jaemin Lee et al. NATURE MEDICINE
- Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood
- (2016) Gilad Twig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
- (2016) Peter Kühnen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- It Takes Two to Tango
- (2016) Jean L. Chan et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Clinical and echographic characteristics of patients exposed to fenfluramin or its derivatives: Results of a prospective, single-centre, observational study
- (2015) David Cambon et al. Archives of Cardiovascular Diseases
- Treatment of Obesity with Celastrol
- (2015) Junli Liu et al. CELL
- Biologic Responses to Weight Loss and Weight Regain: Report From an American Diabetes Association Research Symposium
- (2015) Rudolph L. Leibel et al. DIABETES
- Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice
- (2015) C. Clemmensen et al. EMBO Molecular Medicine
- KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration
- (2015) Sara T. Hjuler et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PYY3–36: Beyond food intake
- (2015) Ulrike Stadlbauer et al. FRONTIERS IN NEUROENDOCRINOLOGY
- The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom
- (2015) J F Hayes et al. INTERNATIONAL JOURNAL OF OBESITY
- Global burden of cancer attributable to high body-mass index in 2012: a population-based study
- (2015) Melina Arnold et al. LANCET ONCOLOGY
- Genetic studies of body mass index yield new insights for obesity biology
- (2015) Adam E. Locke et al. NATURE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- NIH working group report-using genomic information to guide weight management: From universal to precision treatment
- (2015) Molly S. Bray et al. Obesity
- Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
- (2015) R. J. Perry et al. SCIENCE
- Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk
- (2015) S. Wharton et al. Current Cardiology Reports
- Ghrelin
- (2015) T.D. Müller et al. Molecular Metabolism
- Defining the neural basis of appetite and obesity: from genes to behaviour
- (2014) I. S. Farooqi CLINICAL MEDICINE
- Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents
- (2014) J. L. Trevaskis et al. DIABETES OBESITY & METABOLISM
- Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial
- (2014) R V Seimon et al. INTERNATIONAL JOURNAL OF OBESITY
- Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents
- (2014) C. P. Walter et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
- (2014) Ursula E Bauer et al. LANCET
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Amylin Modulates the Mesolimbic Dopamine System to Control Energy Balance
- (2014) Elizabeth G Mietlicki-Baase et al. NEUROPSYCHOPHARMACOLOGY
- Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index
- (2014) Clive J. Hoggart et al. PLoS Genetics
- GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
- (2013) C. Clemmensen et al. DIABETES
- Rapid Improvement of Hepatic Steatosis after Initiation of Leptin Substitution in a Leptin-Deficient Girl
- (2013) J. von Schnurbein et al. Hormone Research in Paediatrics
- Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
- (2013) Louis J. Aronne et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture
- (2013) Lea K. Davis et al. PLoS Genetics
- The Return of Rainbow Diet Pills
- (2012) Pieter A. Cohen et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques
- (2012) P. Kievit et al. DIABETES
- Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models
- (2012) Jason R. Clapper et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Glucagon-Like Peptide 1 (GLP-1) Analogue, Exendin-4, Decreases the Rewarding Value of Food: A New Role for Mesolimbic GLP-1 Receptors
- (2012) S. L. Dickson et al. JOURNAL OF NEUROSCIENCE
- Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21
- (2012) Timo D. Müller et al. JOURNAL OF PEPTIDE SCIENCE
- Genome-wide association studies of obesity and metabolic syndrome
- (2012) Tove Fall et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Biology's response to dieting: the impetus for weight regain
- (2011) Paul S. MacLean et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The utility of animal models to evaluate novel anti-obesity agents
- (2011) Steven P Vickers et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes
- (2011) RJ Bailey et al. BRITISH JOURNAL OF PHARMACOLOGY
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake
- (2011) Amber L. Alhadeff et al. ENDOCRINOLOGY
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
- (2011) A Astrup et al. INTERNATIONAL JOURNAL OF OBESITY
- The medical care costs of obesity: An instrumental variables approach
- (2011) John Cawley et al. JOURNAL OF HEALTH ECONOMICS
- Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake
- (2011) A. M. Dossat et al. JOURNAL OF NEUROSCIENCE
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
- (2011) Tibor Kempf et al. NATURE MEDICINE
- A guide to analysis of mouse energy metabolism
- (2011) Matthias H Tschöp et al. NATURE METHODS
- Ghrelin directly targets the ventral tegmental area to increase food motivation
- (2011) K.P. Skibicka et al. NEUROSCIENCE
- Blood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity
- (2011) Ed J. Hendricks et al. Obesity
- Ghrelin and appetite control in humans—Potential application in the treatment of obesity
- (2011) Michael Patterson et al. PEPTIDES
- Leptin is an effective treatment for hypothalamic amenorrhea
- (2011) S. H. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates
- (2010) Nicholas T. Bello et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
- (2010) D. A. Sarruf et al. DIABETES
- Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity
- (2010) J. G. Kang et al. DIABETES OBESITY & METABOLISM
- Fatal and Non-Fatal Cardiovascular Events in a General Population Prescribed Sibutramine in New Zealand
- (2010) Mira Harrison-Woolrych et al. DRUG SAFETY
- The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: Comparison to sibutramine and rimonabant
- (2010) Henrik H. Hansen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Long-term weight loss maintenance in the United States
- (2010) J L Kraschnewski et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Body-Mass Index and Mortality among 1.46 Million White Adults
- (2010) Amy Berrington de Gonzalez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor
- (2010) B. P. Barnett et al. SCIENCE
- Ten Putative Contributors to the Obesity Epidemic
- (2009) Emily J. McAllister et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Mechanisms of Amylin/Leptin Synergy in Rodent Models
- (2009) Victoria F. Turek et al. ENDOCRINOLOGY
- Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
- (2009) C M Mack et al. INTERNATIONAL JOURNAL OF OBESITY
- Control of food intake and energy expenditure by amylin—therapeutic implications
- (2009) T A Lutz INTERNATIONAL JOURNAL OF OBESITY
- Progressive Postnatal Motoneuron Loss in Mice Lacking GDF-15
- (2009) J. Strelau et al. JOURNAL OF NEUROSCIENCE
- Homeostatic and Hedonic Signals Interact in the Regulation of Food Intake
- (2009) Michael Lutter et al. JOURNAL OF NUTRITION
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
- (2009) Prospective Studies Collaboration LANCET
- An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice
- (2009) S.-C. Lu et al. MOLECULAR PHARMACOLOGY
- Human genetics illuminates the paths to metabolic disease
- (2009) Stephen O’Rahilly NATURE
- Causes and control of excess body fat
- (2009) Jeffrey M. Friedman NATURE
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
- (2009) Eric Ravussin et al. Obesity
- Interaction of Leptin and Amylin in the Long-term Maintenance of Weight Loss in Diet-induced Obese Rats
- (2009) James L. Trevaskis et al. Obesity
- Leptin resistance: a prediposing factor for diet-induced obesity
- (2008) Philip J. Scarpace et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development
- (2008) Andrea M. Haqq et al. CLINICAL ENDOCRINOLOGY
- Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program
- (2008) L. Van Gaal et al. DIABETES CARE
- Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes
- (2008) Y. Seino et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes
- (2008) P. V. Højberg et al. DIABETOLOGIA
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms
- (2008) James L. Trevaskis et al. ENDOCRINOLOGY
- Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
- (2008) W. J. Thomsen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2008) Arne Astrup et al. LANCET
- Differential expression of hypothalamic CART mRNA in response to body weight change following different dietary interventions
- (2008) Yinghua Yu et al. NEUROCHEMISTRY INTERNATIONAL
- Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes
- (2008) Valeriya Lyssenko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
- (2008) J. D. Roth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Review Paper: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns
- (2008) C. S. Elangbam VETERINARY PATHOLOGY
- Characterization of Adult Ghrelin and Ghrelin Receptor Knockout Mice under Positive and Negative Energy Balance
- (2007) Yuxiang Sun et al. ENDOCRINOLOGY
- Leptin Regulation of Agrp and Npy mRNA in the Rat Hypothalamus
- (2003) J. Korner et al. JOURNAL OF NEUROENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More